SMARCB1缺陷瘤的细胞病理学和细胞病理学特征以及与分子和免疫组织化学发现的相关性

Sandra Ixchel Sanchez1, Christina Adams1, Peter Illei1

  • 1Department of Pathology, The Johns Hopkins University School of Medicine and the Johns Hopkins Hospital, Baltimore, MD, United States.

Human pathology
|November 12, 2025
PubMed
概括

缺少SMARCB1的瘤是具有可变形态的侵袭性瘤. 识别这些瘤对于有效的管理至关重要,特别是新兴的向治疗,如EZH2抑制剂.